Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Little Green Pharma Ltd. ( (AU:LGP) ) has shared an announcement.
Little Green Pharma Ltd announced a correction to its previously released Appendix 3Y, clarifying that the number of unlisted options acquired by Fleta Jennifer Solomon was 1.2 million, not 2 million as initially reported. This correction ensures accurate disclosure and maintains transparency with stakeholders, reinforcing the company’s commitment to regulatory compliance.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a leading global medicinal cannabis company with vertically integrated operations across Europe and Australia. The company offers a diverse portfolio of cannabis-based medicines distributed across Australia and over 12 export markets. It operates three production facilities in Denmark and Australia, positioning itself as a key player in global medicinal cannabis markets.
Average Trading Volume: 198,687
Technical Sentiment Signal: Buy
Current Market Cap: A$39.73M
See more data about LGP stock on TipRanks’ Stock Analysis page.